Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics of PSI-697 in healthy smokers
NCT03860506Phase 1Completed
- Sponsor
- Pfizer
- Start
- Apr 2008
- Primary completion
- Jul 2008
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in thrombosis comparing PSI-697 with Placebo (2 arms). Primary endpoint: reduction of platelet monocyte aggregates at 2 days. Started Apr 2008; status: completed.
02
Drugs
psi-697
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT03860506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03860506.